Cargando…
Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study
BACKGROUND: Coronavirus disease is still a global public health emergency. Due to an inadequate healthcare system in low-income nations like Ethiopia, the pandemic has had a devastating impact. Despite this, information on the severity of COVID-19 and related difficulties in Ethiopia is sparse. Ther...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139343/ https://www.ncbi.nlm.nih.gov/pubmed/35634568 http://dx.doi.org/10.2147/JMDH.S361061 |
_version_ | 1784714837385805824 |
---|---|
author | Yemata, Getaneh Atikilt Tesfaw, Aragaw Mihret, Gashaw Tiruneh, Mulu Walle, Zebader Molla, Eshetie Sisay, Ermias Admassu, Fitalew Tadele Habtie, Eyaya Desalagn, Tsion Shimels, Habtamu Teshome, Fentaw |
author_facet | Yemata, Getaneh Atikilt Tesfaw, Aragaw Mihret, Gashaw Tiruneh, Mulu Walle, Zebader Molla, Eshetie Sisay, Ermias Admassu, Fitalew Tadele Habtie, Eyaya Desalagn, Tsion Shimels, Habtamu Teshome, Fentaw |
author_sort | Yemata, Getaneh Atikilt |
collection | PubMed |
description | BACKGROUND: Coronavirus disease is still a global public health emergency. Due to an inadequate healthcare system in low-income nations like Ethiopia, the pandemic has had a devastating impact. Despite this, information on the severity of COVID-19 and related difficulties in Ethiopia is sparse. Therefore, we aimed to determine the survival time to severity and predictors of COVID-19 in Northwest Ethiopia. METHODS: A prospective follow-up study was conducted among 202 adult COVID-19 patients in the South Gondar zone treatment centers. Data were entered using EpiData version 3.1 and then exported to Stata 16 for analysis. Kaplan–Meier was used to estimate mean survival time, and Log rank tests were used to compare survival time between explanatory variable groups. A cox-proportional hazards regression model with a 95% confidence interval and a p-value of 0.05 was used to identify covariates associated with the outcome variable. RESULTS: The patients’ average age was 41.2 years. With an IQR of 4–7 days, the median time to COVID-19 severity was 5 days. The overall COVID-19 severity rate was 6.35 (95% CI: 5.17–7.86) per 100 person-days observed. Senior adult age group (51–59 years) (AHR = 3.59, 95% CI: 1.05, 12.23), elderly age group (≥60 years) (AHR = 2.11, 95% CI: 1.09, 12.67), comorbidity (AHR = 3.26, 95% CI: 1.48, 7.18), high blood pressure at admission (AHR = 4.36, 95% CI: 1.99, 9.54), and high temperature at admission (AHR = 5.60, 95% CI: 2.55, 12.46) were significantly associated with COVID-19 severity time. CONCLUSION AND RECOMMENDATION: Patients with COVID-19 had a short median severity time, and factors like older age, comorbidity, high temperature, and high blood pressure were all independent predictors of severity time. Patients with high body temperature, blood pressure, comorbidity, and advanced age should be the focus of interventions to reduce progression time and improve clinical outcomes. |
format | Online Article Text |
id | pubmed-9139343 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-91393432022-05-28 Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study Yemata, Getaneh Atikilt Tesfaw, Aragaw Mihret, Gashaw Tiruneh, Mulu Walle, Zebader Molla, Eshetie Sisay, Ermias Admassu, Fitalew Tadele Habtie, Eyaya Desalagn, Tsion Shimels, Habtamu Teshome, Fentaw J Multidiscip Healthc Original Research BACKGROUND: Coronavirus disease is still a global public health emergency. Due to an inadequate healthcare system in low-income nations like Ethiopia, the pandemic has had a devastating impact. Despite this, information on the severity of COVID-19 and related difficulties in Ethiopia is sparse. Therefore, we aimed to determine the survival time to severity and predictors of COVID-19 in Northwest Ethiopia. METHODS: A prospective follow-up study was conducted among 202 adult COVID-19 patients in the South Gondar zone treatment centers. Data were entered using EpiData version 3.1 and then exported to Stata 16 for analysis. Kaplan–Meier was used to estimate mean survival time, and Log rank tests were used to compare survival time between explanatory variable groups. A cox-proportional hazards regression model with a 95% confidence interval and a p-value of 0.05 was used to identify covariates associated with the outcome variable. RESULTS: The patients’ average age was 41.2 years. With an IQR of 4–7 days, the median time to COVID-19 severity was 5 days. The overall COVID-19 severity rate was 6.35 (95% CI: 5.17–7.86) per 100 person-days observed. Senior adult age group (51–59 years) (AHR = 3.59, 95% CI: 1.05, 12.23), elderly age group (≥60 years) (AHR = 2.11, 95% CI: 1.09, 12.67), comorbidity (AHR = 3.26, 95% CI: 1.48, 7.18), high blood pressure at admission (AHR = 4.36, 95% CI: 1.99, 9.54), and high temperature at admission (AHR = 5.60, 95% CI: 2.55, 12.46) were significantly associated with COVID-19 severity time. CONCLUSION AND RECOMMENDATION: Patients with COVID-19 had a short median severity time, and factors like older age, comorbidity, high temperature, and high blood pressure were all independent predictors of severity time. Patients with high body temperature, blood pressure, comorbidity, and advanced age should be the focus of interventions to reduce progression time and improve clinical outcomes. Dove 2022-05-23 /pmc/articles/PMC9139343/ /pubmed/35634568 http://dx.doi.org/10.2147/JMDH.S361061 Text en © 2022 Yemata et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Yemata, Getaneh Atikilt Tesfaw, Aragaw Mihret, Gashaw Tiruneh, Mulu Walle, Zebader Molla, Eshetie Sisay, Ermias Admassu, Fitalew Tadele Habtie, Eyaya Desalagn, Tsion Shimels, Habtamu Teshome, Fentaw Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study |
title | Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study |
title_full | Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study |
title_fullStr | Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study |
title_full_unstemmed | Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study |
title_short | Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study |
title_sort | survival time to covid-19 severity and its predictors in south gondar zone, north-west ethiopia: a prospective cohort study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139343/ https://www.ncbi.nlm.nih.gov/pubmed/35634568 http://dx.doi.org/10.2147/JMDH.S361061 |
work_keys_str_mv | AT yematagetanehatikilt survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy AT tesfawaragaw survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy AT mihretgashaw survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy AT tirunehmulu survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy AT wallezebader survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy AT mollaeshetie survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy AT sisayermias survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy AT admassufitalewtadele survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy AT habtieeyaya survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy AT desalagntsion survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy AT shimelshabtamu survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy AT teshomefentaw survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy |